141 related articles for article (PubMed ID: 8200088)
1. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.
Ahotupa M; Hirsimäki P; Pärssinen R; Mäntylä E
Carcinogenesis; 1994 May; 15(5):863-8. PubMed ID: 8200088
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis.
Kärki A; Mäntylä E; Hirsimäki Y; Karlsson S; Toikkanen S; Hirsimäki P
Arch Toxicol; 2000 Jul; 74(4-5):249-56. PubMed ID: 10959800
[TBL] [Abstract][Full Text] [Related]
3. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
[TBL] [Abstract][Full Text] [Related]
4. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.
Williams GM; Iatropoulos MJ; Karlsson S
Carcinogenesis; 1997 Nov; 18(11):2247-53. PubMed ID: 9395228
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens.
Hirsimäki P; Hirsimäki Y; Nieminen L; Payne BJ
Arch Toxicol; 1993; 67(1):49-54. PubMed ID: 8452480
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.
Dragan VP; Vaughan J; Jordan VC; Pitot HC
Carcinogenesis; 1995 Nov; 16(11):2733-41. PubMed ID: 7586193
[TBL] [Abstract][Full Text] [Related]
7. Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.
Stanley LA; Carthew P; Davies R; Higginson F; Martin E; Styles JA
Cancer Lett; 2001 Sep; 171(1):27-35. PubMed ID: 11485825
[TBL] [Abstract][Full Text] [Related]
8. Alterations in hepatic peroxidation mechanisms in thioacetamide-induced tumors in rats. Effect of a rhodium(III) complex.
Cascales M; Martín-Sanz P; Craciunescu DG; Mayo I; Aguilar A; Robles-Chillida EM; Cascales C
Carcinogenesis; 1991 Feb; 12(2):233-40. PubMed ID: 1671654
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of fat-related modulation of N-nitrosodiethylamine-induced tumors in rats: organ distribution, blood lipids, enzymes and pro-oxidant state.
Hietanen E; Bartsch H; Ahotupa M; Béréziat JC; Bussacchini-Griot V; Cabral JR; Camus AM; Laitinen M; Wild H
Carcinogenesis; 1991 Apr; 12(4):591-600. PubMed ID: 1672840
[TBL] [Abstract][Full Text] [Related]
10. On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice.
Caballero F; Gerez E; Oliveri L; Falcoff N; Batlle A; Vazquez E
Int J Biochem Cell Biol; 2001 Jul; 33(7):681-90. PubMed ID: 11390276
[TBL] [Abstract][Full Text] [Related]
11. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.
Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M
Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724
[TBL] [Abstract][Full Text] [Related]
12. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC
Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice.
Tabassum H; Parvez S; Rehman H; Dev Banerjee B; Siemen D; Raisuddin S
Hum Exp Toxicol; 2007 Jun; 26(6):509-18. PubMed ID: 17698946
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
Fan PW; Zhang F; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
[TBL] [Abstract][Full Text] [Related]
15. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
Styles JA; Davies A; Davies R; White IN; Smith LL
Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
[TBL] [Abstract][Full Text] [Related]
16. The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats.
Chen HW; Tsai CW; Yang JJ; Liu CT; Kuo WW; Lii CK
Br J Nutr; 2003 Feb; 89(2):189-200. PubMed ID: 12575903
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats.
Dragan YP; Shimel RJ; Bahnub N; Sattler G; Vaughan JR; Jordan VC; Pitot HC
Toxicol Sci; 1998 Jun; 43(2):129-38. PubMed ID: 9710954
[TBL] [Abstract][Full Text] [Related]
18. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver.
Montandon F; Williams GM
Arch Toxicol; 1994; 68(4):272-5. PubMed ID: 8067901
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expression.
Nuwaysir EF; Dragan YP; McCague R; Martin P; Mann J; Jordan VC; Pitot HC
Biochem Pharmacol; 1998 Aug; 56(3):321-7. PubMed ID: 9744569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
